Invention Grant
- Patent Title: Oral dosage form
-
Application No.: US16574402Application Date: 2019-09-18
-
Publication No.: US11033589B2Publication Date: 2021-06-15
- Inventor: Rolf Daniels , Anja Hoffmann , Marcus Götz , Jörg Fischer , Kerstin Holmgren
- Applicant: Symrise AG
- Applicant Address: DE Holzminden
- Assignee: Symrise AG
- Current Assignee: Symrise AG
- Current Assignee Address: DE Holzminden
- Agency: Dilworth & Barrese, LLP
- Priority: EP15184849 20150911,EP15193826 20151110
- Main IPC: A61K35/747
- IPC: A61K35/747 ; A61K9/00 ; A61K9/20 ; A61K35/00 ; G01N33/50 ; A61K9/19

Abstract:
The present invention is in the field of delivering an active substance to the oral cavity and relates to mucoadhesive active composition and corresponding mucoadhesive dosage form, which can deliver an active substance within the oral cavity, especially an orodispersible tablet for delivering probiotic substance. The present invention also relates to a method of producing the said composition and a method of processing the composition into a mucoadhesive dosage form, especially an orodispersible tablet. The present invention moreover relates to a system and a method for testing the mucoadhesion of a dosage form.
Public/Granted literature
- US20200078422A1 ORAL DOSAGE FORM Public/Granted day:2020-03-12
Information query
IPC分类: